27475696|t|Estrogen and Progesterone hormone receptor expression in oral cavity cancer
27475696|a|Recent studies have shown an increase in the incidence of oral squamous cell carcinoma (OSCC) in younger patients. The hypothesis that tumors could be hormonally induced during pregnancy or in young female patients without the well-known risk factors alcohol or tobacco abuse seems to be plausible. Estrogen Receptor alpha (ERα) and Progesterone Receptor (PR) expression were analyzed in normal oral mucosa (n=5), oral precursor lesions (simple hyperplasia, n=11; squamous intraepithelial neoplasia, SIN I-III, n=35), and OSCC specimen. OSCCs were stratified in a young female (n=7) study cohort and older patients (n=46). In the young female study cohort three patients (n=3/7) developed OSCC during or shortly after pregnancy. Breast cancer tissues were used as positive control for ERα and PR expression. ERα expression was found in four oral precursor lesions (squamous intraepithelial neoplasia, SIN I-III, n=4/35, 11%) and in five OSCC specimen (n=5/46, 11%). The five ERα positive OSCC samples were older male patients. All patients within the young female study cohort were negatively stained for both ERα and PR. ER expression could be regarded as a seldom risk factor for OSCC. PR expression seems to be not relevant for the development of OSCC.
27475696	0	8	Estrogen	T109,T121,T125	C0014939
27475696	13	25	Progesterone	T109,T121,T125	C0033308
27475696	26	33	hormone	T125	C0019932
27475696	34	53	receptor expression	T045	C0597360
27475696	57	75	oral cavity cancer	T191	C0151546
27475696	105	113	increase	T169	C0442805
27475696	121	130	incidence	T081	C0021149
27475696	134	162	oral squamous cell carcinoma	T191	C0585362
27475696	164	168	OSCC	T191	C0585362
27475696	173	180	younger	T079	C0332239
27475696	181	189	patients	T101	C0030705
27475696	195	205	hypothesis	T078	C1512571
27475696	211	217	tumors	T191	C0027651
27475696	227	237	hormonally	T125	C0019932
27475696	238	245	induced	T169	C0205263
27475696	253	262	pregnancy	T040	C0032961
27475696	269	274	young	T079	C0332239
27475696	275	281	female	T032	C0086287
27475696	282	290	patients	T101	C0030705
27475696	314	326	risk factors	T033	C0035648
27475696	327	334	alcohol	T048	C0085762
27475696	338	351	tobacco abuse	T048	C0040336
27475696	375	398	Estrogen Receptor alpha	T116,T192	C0665341
27475696	400	403	ERα	T116,T192	C0665341
27475696	409	430	Progesterone Receptor	T116,T192	C0034833
27475696	432	434	PR	T116,T192	C0034833
27475696	436	446	expression	T045	C0597360
27475696	452	460	analyzed	T062	C0936012
27475696	471	482	oral mucosa	T023	C0026639
27475696	490	512	oral precursor lesions	T033	C0221198
27475696	514	532	simple hyperplasia	T047	C0456483
27475696	540	574	squamous intraepithelial neoplasia	T191	C1302751
27475696	576	585	SIN I-III	T191	C1302751
27475696	598	602	OSCC	T191	C0585362
27475696	603	611	specimen	T167	C0370003
27475696	613	618	OSCCs	T191	C0585362
27475696	624	634	stratified	T080	C0205363
27475696	640	645	young	T079	C0332239
27475696	646	652	female	T032	C0086287
27475696	665	671	cohort	T098	C0599755
27475696	676	681	older	T098	C3826770
27475696	682	690	patients	T101	C0030705
27475696	706	711	young	T079	C0332239
27475696	712	718	female	T032	C0086287
27475696	725	731	cohort	T098	C0599755
27475696	738	746	patients	T101	C0030705
27475696	765	769	OSCC	T191	C0585362
27475696	794	803	pregnancy	T040	C0032961
27475696	805	818	Breast cancer	T191	C0678222
27475696	819	826	tissues	T024	C0040300
27475696	840	856	positive control	T077	C1883676
27475696	861	864	ERα	T116,T192	C0665341
27475696	869	871	PR	T116,T192	C0034833
27475696	872	882	expression	T045	C0597360
27475696	884	887	ERα	T116,T192	C0665341
27475696	888	898	expression	T045	C0597360
27475696	917	939	oral precursor lesions	T033	C0221198
27475696	941	975	squamous intraepithelial neoplasia	T191	C1302751
27475696	977	986	SIN I-III	T191	C1302751
27475696	1013	1017	OSCC	T191	C0585362
27475696	1018	1026	specimen	T167	C0370003
27475696	1051	1054	ERα	T116,T192	C0665341
27475696	1055	1063	positive	T033	C1446409
27475696	1064	1068	OSCC	T191	C0585362
27475696	1069	1076	samples	T167	C0370003
27475696	1082	1087	older	T098	C3826770
27475696	1088	1092	male	T032	C0086582
27475696	1093	1101	patients	T101	C0030705
27475696	1107	1115	patients	T101	C0030705
27475696	1127	1132	young	T079	C0332239
27475696	1133	1139	female	T032	C0086287
27475696	1146	1152	cohort	T098	C0599755
27475696	1158	1168	negatively	T033	C0205160
27475696	1186	1189	ERα	T116,T192	C0665341
27475696	1194	1196	PR	T116,T192	C0034833
27475696	1198	1200	ER	T116,T192	C0034804
27475696	1201	1211	expression	T045	C0597360
27475696	1235	1241	seldom	T080	C0522498
27475696	1242	1253	risk factor	T033	C0035648
27475696	1258	1262	OSCC	T191	C0585362
27475696	1264	1266	PR	T116,T192	C0034833
27475696	1267	1277	expression	T045	C0597360
27475696	1294	1302	relevant	T080	C2347946
27475696	1311	1322	development	T169	C1527148
27475696	1326	1330	OSCC	T191	C0585362